N※N

FDA Reevaluating Safety of Common Food Preservative BHA

  //food-wine.news-articles.net/content/2026/04/07 .. ting-safety-of-common-food-preservative-bha.html
  Published in Food and Wine on Tuesday, April 7th 2026 at 11:21 GMT by WDIO
      Locale: UNITED STATES

WASHINGTON (AP) -- The Food and Drug Administration (FDA) announced today, Tuesday, April 7th, 2026, that it is initiating a comprehensive reevaluation of the safety of butylated hydroxyanisole (BHA), a widely used synthetic antioxidant and preservative commonly found in a vast array of processed foods. The move follows mounting concerns, fueled by recent research, regarding the potential link between BHA exposure and cancer, prompting a critical look at a food additive that has been a staple of the American diet for over seventy years.

BHA, initially approved by the FDA in 1947, functions by preventing fats and oils from oxidizing, thus delaying rancidity and extending the shelf life of numerous products. Consumers encounter BHA in everyday items such as potato chips, cereals, chewing gum, baked goods, fast food packaging, and even cosmetics. Its prevalence highlights the significant role it plays in the modern food industry, where maintaining product freshness and reducing waste are paramount.

The catalyst for this reassessment is a recent review conducted by the National Toxicology Program (NTP). The NTP's findings revealed "some evidence" of carcinogenicity in laboratory animals exposed to BHA. While it's crucial to note that animal studies don't automatically translate to human risk, the data has triggered a cautious response from the FDA. The agency emphasized it is taking the concerns seriously and will base its decisions on the totality of available scientific evidence. The specific animal studies indicated increased incidence of squamous cell carcinomas of the forestomach in rats and, to a lesser extent, other tumor types. This has led experts to question whether similar mechanisms could be at play in humans, particularly regarding the digestive system.

"We are aware of the recent concerns regarding BHA and are taking them seriously," stated an FDA spokesperson. "We are actively reviewing the available data and information, including the NTP report, and will make a determination based on the best available science. Public input is a vital part of this process, and we encourage anyone with relevant data to submit it."

The FDA's call for public comment signifies a commitment to transparency and inclusivity in its regulatory process. This allows independent researchers, consumer advocacy groups, and industry stakeholders to contribute to the ongoing evaluation. The agency has established a dedicated portal on its website for submissions and has set a 90-day window for the collection of data.

Consumer advocacy groups, such as the Environmental Working Group (EWG), have been vocal critics of BHA for years, consistently citing concerns about its potential health risks and calling for stricter regulation. The EWG welcomes the FDA's renewed scrutiny. "We're glad to see the FDA taking a closer look at BHA," said Sarah Peterson, a spokesperson for the EWG. "It's important that we ensure the safety of the food we eat, and this preservative has been under the radar for far too long." The EWG has previously published reports detailing the levels of BHA found in various food products and highlighting potential health concerns.

The potential outcomes of the FDA's reassessment are varied. The agency could reaffirm its current stance, concluding that BHA is safe at current levels of exposure. However, more stringent regulations are also possible. These could include restricting the use of BHA in certain food categories, establishing stricter limits on its concentration, or mandating warning labels on products containing the preservative. A complete ban on BHA, while unlikely given its widespread use, remains a possibility if compelling evidence of harm emerges.

Beyond the immediate health concerns, this review also underscores a broader debate about the role of synthetic additives in the food supply. As consumers become increasingly aware of the ingredients in their food, there's a growing demand for natural and minimally processed alternatives. This shift in consumer preferences is driving innovation in the food industry, with companies exploring natural preservatives such as rosemary extract, vitamin E, and ascorbic acid as potential replacements for BHA.

The FDA is expected to release preliminary findings from its review in late 2026, with a final decision anticipated in early 2027. This timeline allows for a thorough evaluation of the submitted data and ensures a science-based approach to regulating this common food preservative.